180 Life Sciences (ATNF) Short Interest Ratio & Short Volume $3.74 -0.18 (-4.59%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends 180 Life Sciences Short Interest Data180 Life Sciences (ATNF) has a short interest of 78,700 shares, representing 16.06% of the float (the number of shares available for trading by the public). This marks a 7.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 828,361 shares to cover all short positions.Current Short Interest78,700 sharesPrevious Short Interest73,300 sharesChange Vs. Previous Month+7.37%Dollar Volume Sold Short$119,624.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares1,030,000 sharesFloat Size489,900 sharesShort Percent of Float16.06%Today's Trading Volume159,631 sharesAverage Trading Volume828,361 sharesToday's Volume Vs. Average19% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNF Short Interest Over TimeATNF Days to Cover Over TimeATNF Percentage of Float Shorted Over Time Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202478,700 shares $119,624.00 +7.4%16.1%0 $1.52 9/30/202473,300 shares $123,877.00 +21.0%14.1%0.8 $1.69 9/15/202460,600 shares $109,686.00 +78.8%11.7%0.1 $1.81 8/31/202433,900 shares $61,359.00 +5.3%6.5%0.1 $1.81 8/15/202432,200 shares $60,536.00 -29.7%6.2%0.1 $1.88 7/31/202445,800 shares $95,264.00 -67.5%8.8%0.1 $2.08 Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024140,800 shares $285,824.00 +249.4%27.2%0.2 $2.03 6/30/202440,300 shares $66,495.00 +13.2%7.8%0.1 $1.65 6/15/202435,600 shares $55,180.00 -19.8%6.9%0.3 $1.55 5/31/202444,400 shares $71,928.00 +156.7%8.6%0.3 $1.62 5/15/202417,300 shares $33,562.00 -36.9%3.4%0.1 $1.94 4/30/202427,400 shares $58,910.00 +60.2%5.3%0.3 $2.15 4/15/202417,100 shares $34,542.00 -59.7%3.3%0.2 $2.02 3/31/202442,400 shares $98,792.00 -31.4%8.4%0.4 $2.33 3/15/202461,800 shares $216,300.00 +309.3%12.2%0.6 $3.50 2/29/202415,100 shares $53,152.00 -95.6%3.0%0.2 $3.52 2/15/2024342,100 shares $1.36 million -22.8%3.6%0.3 $3.99 1/31/2024443,300 shares $94,866.20 -61.8%4.6%0.4 $0.21 1/15/20241,160,000 shares $234,552.00 +195.7%12.2%1 $0.20 12/31/2023392,300 shares $83,756.05 -32.9%4.1%0.4 $0.21 12/15/2023584,700 shares $109,923.60 -4.0%6.2%1 $0.19 11/30/2023608,900 shares $165,011.90 +281.3%8.8%1.2 $0.27 11/15/2023159,700 shares $57,476.03 +26.1%2.3%1.2 $0.36 10/31/2023126,700 shares $54,481.00 +21.2%2.3%0.9 $0.43 10/15/2023104,500 shares $58,509.55 -37.3%1.9%0.3 $0.56 9/30/2023166,700 shares $102,103.75 +64.7%3.0%0.5 $0.61 9/15/2023101,200 shares $83,712.64 -30.1%1.8%0.3 $0.83 8/31/2023144,800 shares $96,581.60 -77.1%2.6%0.5 $0.67 8/15/2023632,100 shares $453,847.80 +3,108.6%11.2%1.9 $0.72 7/31/202319,700 shares $18,518.00 -34.8%0.4%0 $0.94 7/15/202330,200 shares $31,408.00 -46.4%0.6%0.1 $1.04 6/30/202356,300 shares $65,871.00 -52.3%1.1%0.1 $1.17 6/15/2023118,000 shares $136,880.00 -27.4%2.4%0.1 $1.16 5/31/2023162,500 shares $185,250.00 +70.3%3.4%0.2 $1.14 5/15/202395,400 shares $98,262.00 -13.2%2.0%0.1 $1.03 4/30/2023109,900 shares $126,385.00 -51.7%2.4%0.2 $1.15 4/15/2023227,500 shares $282,100.00 +106.6%7.2%0.2 $1.24 3/31/2023110,100 shares $198,180.00 +56.0%3.5%0.1 $1.80 3/15/202370,600 shares $146,142.00 -59.2%4.6%0 $2.07 2/28/2023173,000 shares $496,510.00 -7.2%11.2%0 $2.87Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… 2/15/2023186,400 shares $561,064.00 -52.7%11.2%0 $3.01 1/31/2023393,900 shares $1.31 million -26.6%23.6%0.1 $3.33 1/15/2023536,900 shares $1.99 million +3.0%32.2%0.1 $3.71 12/30/2022521,100 shares $1.77 million +1,060.6%31.2%0.1 $3.39 12/15/202244,900 shares $243,986.60 -94.9%2.8%0.1 $5.43 11/30/2022874,900 shares $367,458.00 -0.2%N/A4.4 $0.42 11/15/2022876,800 shares $380,881.92 -3.4%N/A4.6 $0.43 10/31/2022907,300 shares $424,797.86 -11.1%N/A4.2 $0.47 10/15/20221,020,000 shares $520,404.00 +1.0%N/A4.9 $0.51 9/30/20221,010,000 shares $671,650.00 +2.0%N/A4.7 $0.67 9/15/2022990,000 shares $801,999.00 -2.0%N/A5.6 $0.81 8/31/20221,010,000 shares $859,914.00 +9.8%N/A4.7 $0.85 8/15/2022919,500 shares $1.05 million -1.7%N/A3.4 $1.14 7/31/2022935,700 shares $1.02 million +3.9%N/A3.3 $1.09 7/15/2022900,500 shares $1.03 million -8.0%N/A2 $1.14 6/30/2022978,400 shares $829,683.20 -13.4%N/A2.1 $0.85 6/15/20221,130,000 shares $998,920.00 -18.7%N/A2.3 $0.88 5/31/20221,390,000 shares $2.25 million -0.7%N/A3.2 $1.62 5/15/20221,400,000 shares $1.76 million +5.3%N/A3.6 $1.26 4/30/20221,330,000 shares $2.82 million -1.5%N/A3.4 $2.12 4/15/20221,350,000 shares $2.65 million -6.3%N/A4.7 $1.96 3/31/20221,440,000 shares $3.73 million -4.0%N/A4.6 $2.59 3/15/20221,500,000 shares $3.87 million +5.6%N/A4.2 $2.58 2/28/20221,420,000 shares $4.53 million -6.6%N/A2.9 $3.19 2/15/20221,520,000 shares $4.97 million +13.4%N/A1.8 $3.27 1/31/20221,340,000 shares $3.83 million -8.8%N/A1.4 $2.86 1/15/20221,470,000 shares $4.47 million -7.0%N/A1.5 $3.04 12/31/20211,580,000 shares $6.16 million -18.1%N/A1.6 $3.90 12/15/20211,930,000 shares $7.86 million +37.9%N/A2 $4.07 11/30/20211,400,000 shares $8.93 million +2.2%N/A1.3 $6.38 11/15/20211,370,000 shares $5.86 million -16.0%N/A1.8 $4.28 10/29/20211,630,000 shares $8.26 million +16.4%N/A2.4 $5.07 10/15/20211,400,000 shares $7.85 million -4.8%N/A1.9 $5.61 9/30/20211,470,000 shares $7.95 million -33.8%N/A2.1 $5.41 9/15/20212,220,000 shares $14.65 million +14.4%N/A3.3 $6.60 8/31/20211,940,000 shares $11.43 million +116.6%N/A3.9 $5.89 8/13/2021895,800 shares $6.96 million -60.5%N/A2 $7.77 7/30/20212,270,000 shares $17.18 million +3.2%20.3%5.7 $7.57 7/15/20212,200,000 shares $20.17 million -0.5%19.7%5.7 $9.17 6/30/20212,210,000 shares $22.10 million -1.3%24.2%1.7 $10.00 6/15/20212,240,000 shares $22.92 million +2.8%24.6%1 $10.23 5/28/20212,180,000 shares $18.62 million -15.5%23.9%0.9 $8.54 5/14/20212,580,000 shares $17.67 million -9.8%28.3%1 $6.85 4/30/20212,860,000 shares $29.66 million -5.6%31.4%1.1 $10.37 4/15/20213,030,000 shares $31.69 million +25.7%33.2%1 $10.46 3/31/20212,410,000 shares $14.80 million +6.2%26.4%0.8 $6.14 3/15/20212,270,000 shares $14.48 million +6.1%83.5%1.3 $6.38 2/26/20212,140,000 shares $9.44 million +364.0%78.7%1.3 $4.41 2/12/2021461,200 shares $2.73 million +54.6%17.0%0.3 $5.91 1/29/2021298,300 shares $1.04 million -1.8%11.0%0.2 $3.48Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… 1/15/2021303,900 shares $948,168.00 No Change11.2%0.3 $3.12 ATNF Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 78,700 shares of ATNF short. 16.06% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest. What is a good short interest percentage for 180 Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.06% of 180 Life Sciences' floating shares are currently sold short. Is 180 Life Sciences' short interest increasing or decreasing? 180 Life Sciences saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 78,700 shares, an increase of 7.4% from the previous total of 73,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 180 Life Sciences' float size? 180 Life Sciences currently has issued a total of 1,030,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 489,900 shares. How does 180 Life Sciences' short interest compare to its competitors? 16.06% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: Sol-Gel Technologies Ltd. (2.31%), Synlogic, Inc. (0.76%), GeoVax Labs, Inc. (2.69%), HCW Biologics Inc. (0.13%), ImmunoPrecise Antibodies Ltd. (0.67%), Talphera, Inc. (0.21%), Marinus Pharmaceuticals, Inc. (6.34%), Chemomab Therapeutics Ltd. (0.74%), NLS Pharmaceutics Ltd. (2.88%), Tenax Therapeutics, Inc. (0.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Sol-Gel Technologies Short Squeeze Synlogic Short Squeeze GeoVax Labs Short Squeeze HCW Biologics Short Squeeze ImmunoPrecise Antibodies Short Squeeze Talphera Short Squeeze Marinus Pharmaceuticals Short Squeeze Chemomab Therapeutics Short Squeeze NLS Pharmaceutics Short Squeeze Tenax Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
